These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11002457)

  • 1. [The cytosolic hyaluronic acid level defines several clinico-biological properties of CD44v5-positive infiltrating ductal carcinoma of the breast].
    Ruibal A; Arias JI; Carmen del Río M; San Román JM; Lapeña G; Schneider J; Tejerina A
    Med Clin (Barc); 2000 Jul; 115(6):201-7. PubMed ID: 11002457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast].
    Sánchez Salmón A; Argibay S; Arias JI; Ruibal A
    Rev Esp Med Nucl; 2005; 24(3):185-90. PubMed ID: 15847785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infiltrating ductal carcinomas of the breast in women over 60 years of age. Association with higher cellular proliferation and lower PS2, cell surface and cytosolic hyaluronic acid concentrations].
    Ruibal A; Arias J; Del Río MC; Resino C; Tejerina A
    Rev Esp Med Nucl; 2001 Dec; 20(7):525-9. PubMed ID: 11709137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-biological impact of pS2 positivity in estrogen receptor negative-infiltrating ductal carcinomas of the breast].
    Ruibal A; Arias J; del Río MC; San Román JM; Lapeña G; Pardo C; Tejerina A
    Rev Esp Med Nucl; 2000 Oct; 19(6):428-33. PubMed ID: 11060273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the cytosolic concentrations of the tissue poly-peptide specific (TPS) antigen in infiltrating ductal carcinomas of the breast. Positive relationship with hormone dependency and negative with cellular proliferation].
    Ruibal A; Arias JI; Resino C; Lapeña G; Schneider J; Tejerina A
    Rev Esp Med Nucl; 2001 Aug; 20(5):365-8. PubMed ID: 11470070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of epidermal growth factor receptor (EGFR) in hormone-independent breast cancers].
    Ruibal A; Garrido-Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(1):15-9. PubMed ID: 16540006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological grade in breast cancer: association with clinical and biological features in a series of 229 patients.
    Ruibal A; Arias JI; Del Río MC; Lapeña G; Schneider J; Tejerina A
    Int J Biol Markers; 2001; 16(1):56-61. PubMed ID: 11288957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical-biological differences between invasive ductal carcinomas and breast lobular carcinomas. Preliminary results].
    Ruibal A; Núñez MI; del Río Mf; Arias J; Martínez MI; Rabadán J; Tejerina A
    Rev Esp Med Nucl; 1999; 18(2):84-7. PubMed ID: 10352319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative serum CA15.3 and CEA levels and clinical-biological parameters in breast tumors].
    Ruibal A; Garrido Pumar M; Arias JI
    Rev Esp Med Nucl; 2006; 25(3):180-3. PubMed ID: 16762272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of the adhesion molecule CD44v6 in infiltrating ductal carcinomas of the breast is associated with hormone dependence. Our experience with 168 cases].
    Ruibal A; Schneider J; del Río MC; Arias J; Núñez MI; Tejerina A
    Rev Esp Med Nucl; 2000 Sep; 19(5):350-5. PubMed ID: 11062111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer.
    Corte MD; González LO; Lamelas ML; Alvarez A; Junquera S; Allende MT; García-Muñiz JL; Argüelles J; Vizoso FJ
    Breast Cancer Res Treat; 2006 Jun; 97(3):329-37. PubMed ID: 16791488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinicobiological study of membrane hyaluronic acid index /CD44v5 (AHm/CD44v5) in patients with infiltrating ductal breast carcinoma].
    Ruibal A; Arias J; del Río MC; Lapeña G; Resino C; Tejerina A
    Rev Esp Med Nucl; 2000 Aug; 19(4):311-2. PubMed ID: 11062104
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and biological differences between infiltrating ductal carcinomas of the breast in women over 70 years-old and those aged 60-70].
    Ruibal A; Arias JI; Aldecoa B
    Med Clin (Barc); 2002 Dec; 119(20):761-4. PubMed ID: 12525308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].
    Resino C; Arias JI; Del Río MC; Sánchez Hermosa C; Ruibal A
    Rev Esp Med Nucl; 2001 Oct; 20(6):503-5. PubMed ID: 11578586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
    Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
    Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CA 15-3 serum levels in patients with ductal breast carcinoma: relationship with clinicopathological parameters and tumor markers.
    González-Sistal A; Arias JI; Ruibal A
    Int J Biol Markers; 2012; 27(1):47-52. PubMed ID: 21928245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the cytosolic content of the pS2 protein in breast cancer].
    Tamargo F; Vizoso F; Lamelas ML; Rodil A; Vérez P; Raigoso P; Mulero M; Vázquez J; Roiz C; Allende MT
    Rev Esp Med Nucl; 2002 Feb; 21(1):28-33. PubMed ID: 11820999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytosolic tissue-type plasminogen activator (t-PA) levels in ductal infiltrating carcinomas of the breast classified according to different clinical and biological parameters.
    García Muñiz JL; Alvarez A; Fernández Llana B; Fernández Raigoso P; Allende MT; Ruibal A
    Int J Biol Markers; 1995; 10(2):119-21. PubMed ID: 7561238
    [No Abstract]   [Full Text] [Related]  

  • 20. [CYFRA 21.1 cytosol levels in lung adenocarcinomas. Correlation with other clinico-biological parameters].
    Ruibal A; Núñez MI; Del Río MC; Lapeña G; Rodríguez J
    Rev Esp Med Nucl; 2002; 21(5):333-7. PubMed ID: 12236907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.